1. Uses of drug-event assessment;Jones;Drug Inf J,1984
2. US Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER) Center for Biologics Evaluation and Research (CBER) Draft Guidance for Industry: Safety Reporting Requirements for INDs and BA/BE Studies 2010
3. US FDA Final Rule, Investigational New Drug Safety Reporting Requirements for Human Drug and Biological Products and Safety Reporting Requirements for Bioavailability and Bioequivalence Studies in Humans 2010
4. On the methodology of investigations of etiologic factors in chronic diseases;Yerushalmy;J Chronic Dis,1959